Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q4 2024 to Q1 2025
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 2
- Est. +$440.6K
- Added
- 24
- Est. +$6.73M
- Reduced
- 15
- Est. −$48.5M
- Sold out
- 21
- Est. −$89.2M
Portfolio value went from $215.0M to $86.9M (−$128.1M (−59.6%)); positions from 64 to 45 (−19).
All Q1 2025 holdingsAll Q4 2024 holdings
In the shares, value and % of portfolio columns, the top figure is Q1 2025 and the gray one below is Q4 2024. For stocks that split between the two quarters, Q4 2024 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| Vanguard Total International Bond ETF92203J407 | Sold out– | 0318,115 | −318,115−100.0% | $0$15.6M | −$15.6M | 0.0%7.3% | −7.26 |
| iShares Tr464288281 | Sold out– | 0147,400 | −147,400−100.0% | $0$13.1M | −$13.1M | 0.0%6.1% | −6.10 |
| iShares Tr464289883 | Sold out– | 0347,277 | −347,277−100.0% | $0$13.0M | −$13.0M | 0.0%6.0% | −6.02 |
| SPDR Series Trust78464A490 | Sold out– | 0217,606 | −217,606−100.0% | $0$7.87M | −$7.87M | 0.0%3.7% | −3.66 |
| Vanguard Intl Equity Index F922042676 | Sold out– | 0198,721 | −198,721−100.0% | $0$7.86M | −$7.86M | 0.0%3.7% | −3.66 |
| Vanguard World FD921910709 | Sold out– | 0109,780 | −109,780−100.0% | $0$7.43M | −$7.43M | 0.0%3.5% | −3.46 |
| iShares Tr464288588 | Sold out– | 072,363 | −72,363−100.0% | $0$6.63M | −$6.63M | 0.0%3.1% | −3.09 |
| SPDR Series Trust78468R200 | Sold out– | 0160,008 | −160,008−100.0% | $0$4.92M | −$4.92M | 0.0%2.3% | −2.29 |
| Vanguard Real Estate ETF922908553 | Sold out– | 043,422 | −43,422−100.0% | $0$3.87M | −$3.87M | 0.0%1.8% | −1.80 |
| iShares Tr46429B747 | Sold out– | 024,897 | −24,897−100.0% | $0$2.50M | −$2.50M | 0.0%1.2% | −1.16 |
| iShares Trust iShares 0-1 Year Treasury Bond ETF464288679 | Sold out– | 012,248 | −12,248−100.0% | $0$1.35M | −$1.35M | 0.0%0.6% | −0.63 |
| iShares Tr46429B655 | Sold out– | 025,034 | −25,034−100.0% | $0$1.27M | −$1.27M | 0.0%0.6% | −0.59 |
| SPDR Series Trust78468R622 | Sold out– | 012,872 | −12,872−100.0% | $0$1.23M | −$1.23M | 0.0%0.6% | −0.57 |
| iShares Tr464288513 | Sold out– | 06,708 | −6,708−100.0% | $0$527.6K | −$527.6K | 0.0%0.2% | −0.25 |
| State Street Real Estate Select Sector SPDR ETF81369Y860 | Sold out– | 012,735 | −12,735−100.0% | $0$517.9K | −$517.9K | 0.0%0.2% | −0.24 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Sold out– | 04,629 | −4,629−100.0% | $0$494.5K | −$494.5K | 0.0%0.2% | −0.23 |
| ABTAbbott Laboratories | Sold outHistory | 02,683 | −2,683−100.0% | $0$303.7K | −$303.7K | 0.0%0.1% | −0.14 |
| REGNRegeneron Pharmaceuticals, Inc. | Sold outHistory | 0368 | −368−100.0% | $0$262.1K | −$262.1K | 0.0%0.1% | −0.12 |
| Tidal ETF Tr886364603 | Sold out– | 011,701 | −11,701−100.0% | $0$218.6K | −$218.6K | 0.0%0.1% | −0.10 |
| Invesco Exch TRD SLF Idx FD46138J460 | Sold out– | 010,596 | −10,596−100.0% | $0$173.5K | −$173.5K | 0.0%0.1% | −0.08 |
| KRONKronos Bio, Inc. | Sold outHistory | 093,190 | −93,190−100.0% | $0$88.5K | −$88.5K | 0.0%<0.1% | −0.04 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.